IvanRychlik Charles University, Third Faculty of Medicine, Department of Internal MedicineCzech Republic

IvanRychlik

Institution

Day 1 - Sunday April 14, 2024

Time	Session

9 a.m. 10:30 a.m.	Hands on Big Data Mining for the Nephrologist in 2024 HeatherAscani Chairperson ascanihk@med.umich.eduUnited States KatherineTuttle Chairperson Katherine.Tuttle@providence.orgUniversity of Washington, Department of NephrologyUnited States MatthiasKretzler Chairperson kretzler@umich.eduUniversity of MichiganUnited States Looking for Data on Glomerular Diseases: How to Find the Treasures You Are Looking for With a Click of a Mouse VijiNair Speaker vijin@med.umich.eduUniversity of MichiganUnited States Open Science in an Open Community: Resources of the Kidney Precision Medicine Project for CKD and AKI MatthiasKretzler Speaker kretzler@umich.eduUniversity of MichiganUnited States The Future is Now: How to Mine Cells and Neighborhoods of the Kidney in Health and Disease JulioSaez-Rodriguez Speaker julio.saez@uni-heidelberg.deHeidelberg UniversityGermany Panel Discussion Hall C1	Population Health and Strategies to Protect the Fragile EnriqueDorado Chairperson egdorado@gmail.comInstituto de Investigaciones Médicas "A. Lanari". Universidad de Buenos AiresArgentina ShokoufehSavaj Chairperson ssavaj@hotmail.comIran Being Born Too Small: What a Nephrologist Should Know to Support Prevention of CKD in Future Generations DanieleTrevisanuto Speaker daniele.trevisanuto@unipd.itUniversity Hospital of Padova, ItalyItaly Hypertensive Disorders of Pregnancy as a Means to Discover CKD Giorgina BarbaraPiccoli Speaker GBPICCOLI@YAHOO.ITCentre Hospitalier Le MansFrance Managing Pregnancy with Advanced CKD in a Limited-resource Setting AlejandraOrozco Guillen Speaker ale_gaba@hotmail.comNational Institute of Perinatology, Nephrology depMexico Pre-eclampsia and its Differential Diagnosis: A Viewpoint from LMICs RashaShemies Speaker rashasamirtaha@gmail.comMansoura UniversityEgypt Q and A Hall D
2:45 p.m. 3:30 p.m.	What is ongoing in CKDu around the world? - CKDU interactive discussions (ISN i3C) ErangaWijewickrama Spotlight Chairperson erangasw@clinmed.cmb.ac.lkFaculty of Medicine, University of ColomboSri Lanka Jose VicenteSanchez Polo Spotlight Chairperson visanpolo@gmail.comRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH)Guatemala Magdalena Madero Spotlight Speaker madero.magdalena@gmail.comChief of Nephrology, Instituto Nacional de CardiolMexico VivekanandJha Spotlight Speaker vjha@georgeinstitute.org.inGeorge Institute for Global Health IndiaIndia NishanthaNanyakkara Spotlight Speaker nishantha4313@gmail.comSri Lanka Spotlight Stage 1 (exhibition hall)
4 p.m. 4:30 p.m.	Potential Role of Anti-CD38 Therapy in Autoimmune Kidney Diseases like Lupus Nephritis BradRovin Spotlight Speaker rovin.1@osu.eduThe Ohio State UniversityUnited States UptalPatel Spotlight Speaker uptal@hibio.comUnited States Spotlight Stage 1 (exhibition hall)
4:30 p.m. 5:30 p.m.	New Developments in CKD Epidemiology Research MaartenTaal Chairperson maarten.taal1@nhs.netUniversity of NottinghamUnited Kingdom RobertoPecoits Filho Chairperson roberto.pecoits@arborresearch.orgArbor Research Collaborative for HealthUnited States Big Data Lab Patient-reported Outcome Measures: How Do Patients Experience CKD? AdeeraLevin Speaker alevin@providencehealth.bc.caCanada Trial Simulation Using Observational Data AngeloKaraboyas Speaker angelo.karaboyas@arborresearch.orgArbor Research Collaborative for HealthUnited States Using Routinely Collected Big Datasets for Clinical Research in CKD: Opportunities and Challenges DorotheaNitsch Speaker dorothea.nitsch@lshtm.ac.ukLondon School of Hygiene & Tropical MedicineUnited Kingdom Q and A Hall C4

Day 2 - Monday April 15, 2024

Time	Session

11 a.m. 12 p.m.	Plenary Session 3: Generative AI Revolution in Medicine (Michal Rosen-Zvi, Israel) Jose VicenteSanchez Polo Chairperson visanpolo@gmail.comRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH)Guatemala MegJardine Chairperson meg.jardine@sydney.edu.auNHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia Generative AI Revolution in Medicine MichalRosen-Zvi Speaker ROSEN@il.ibm.comhttps://research.ibm.com/Israel Acceptance Speech by Awardee (Schrier Award), with Tasnuva Sarah Kashem (UK) and Farnaz Nobi (Bangladesh) Mohammad Shakib Uz ZamanArefin Speaker shakib04@yahoo.comBangladesh Hall A
12:15 p.m. 1:15 p.m.	It’s Hard to Be a Woman With CKD. WIN/WIN-India Special Session AlejandraOrozco Guillen Chairperson ale_gaba@hotmail.comNational Institute of Perinatology, Nephrology depMexico IvanRychlik Chairperson ivan.rychlik@fnkv.czCharles University, Third Faculty of Medicine, Department of Internal MedicineCzech Republic Rita MarcelaFortunato Chairperson marcelafortunator@gmail.comFundacion Favaloro University Hospital, Faculty of Medicine, University of Buenos AiresArgentina Women and CKD UrmilaAnandh Speaker uanandh@gmail.comAmrita Hospitals, Faridabad, Delhi NCRIndia Pregnancy and CKD Prof LizLightstone Speaker l.lightstone@imperial.ac.ukImperial College LondonUnited Kingdom Pregnancy and Transplantation SilviShah Speaker silvishah2108@gmail.comUniversity of Cincinnati, Ohio, United StatesUnited States Global and African Epidemiology, Management and Outcomes of CKD and dialysis in Men and Women: A Perspective on Gender Disparities RashaDarwish Speaker dr.rasha-darwish@hotmail.comKasr Aleiny medical school , Cairo UniversityEgypt Q and A Hall C4
3 p.m. 4 p.m.	Treatment Goals for Severe Hyponatremia: A Debate on Current Guidelines Program MitchellRosner Chairperson MHR9R@hscmail.mcc.virginia.eduUniveristy of Virginia HealthUnited States Overview of Hyponatremia Angela Yee-MoonWang Speaker angela.wang@duke-nus.edu.sgHong Kong/SingaporeSingapore Pro: Current Guidelines are Appropriate HelbertRondon-Berrios Speaker rondonberriosh@upmc.eduUniversity of Pittsburgh School of MedicineUnited States Con: Current Guidelines are Too Conservative CarlosAyus Speaker carlosayus@yahoo.comUniversity of California IrvineUnited States Discussion Hall C3
4:30 p.m. 5:30 p.m.	Paraproteinemia and the Kidney CarolineLamarche Chairperson caroline.lamarche.1@umontreal.caUniversité de MontréalCanada Gustavo CristianGreloni Chairperson gustavo.greloni@hospitalitaliano.org.arArgentina MGRS: Should All Forms Need Clonal Therapy? FrankBridoux Speaker f.bridoux@chu-poitiers.frDepartment of Nephrology and French Reference Center for AL amyloidosis and MGRS, University Hospital, Poitiers, FranceFrance Renal Amyloidosis: What Is New? Veronica Torres CostaSilva Speaker veronica.torres@hc.fm.usp.brSão Paulo State Cancer Institute - University of São PauloBrazil Can We Perform a Transplant in Patients with Myeloma and Amyloidosis? SabineKaram Speaker sabinejkaram@gmail.comUniversity of MinnesotaLebanon Q and A Hall A

Day 3 - Tuesday April 16, 2024

Time	Session

9 a.m. 10 a.m.	Type 2 Diabetes in Kidney Disease: Recent Updates and Best Practices for Detection and Treatment DebasishBanerjee Chairperson dbanerje@sgul.ac.ukSt George's University Hospital NHS Foundation TrUnited Kingdom MegJardine Chairperson meg.jardine@sydney.edu.auNHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia Setting the Scene MegJardine Speaker meg.jardine@sydney.edu.auNHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia DM and CKD: Which Treatment Should I Use for Different Populations? KatherineTuttle Speaker Katherine.Tuttle@providence.orgUniversity of Washington, Department of NephrologyUnited States How to Design Studies on Answering Unanswered Questions VladoPerkovic Speaker vlado.perkovic@unsw.edu.auUniversity of New South Wales, Sydney, AustraliaAustralia The Effect of SGLT2 Inhibitors in Patients with Chronic Kidney Disease, With or Without Type 2 Diabetes DavidWheeler Speaker d.wheeler@ucl.ac.ukUniversity College LondonUnited Kingdom Q and A Hall C4